SCHEMBL14865731

SCHEMBL14865731

CCCCCCCCSCC(O)COCCOCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.50
HTT P42858 2/20 0.49
PLA2G4B P0C869 1/20 0.45
LPAR5 Q9H1C0 1/20 0.43
HSD17B10 Q99714 2/20 0.41
PRKD3 O94806 3/20 0.41
PRKCG P05129 3/20 0.41
PRKCB P05771 3/20 0.41
PRKCA P17252 3/20 0.41
PRKCH P24723 3/20 0.41
PRKCI P41743 3/20 0.41
PRKCE Q02156 3/20 0.41
PRKCQ Q04759 3/20 0.41
PRKCZ Q05513 3/20 0.41
PRKCD Q05655 3/20 0.41
PRKD1 Q15139 3/20 0.41
THRB P10828 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11734486 0.92 USP2 (0.56) USP2HTTPLA2G4BLPAR5HSD17B10
SCHEMBL11741330 0.92 USP2 (0.56) USP2HTTPLA2G4BLPAR5HSD17B10
SCHEMBL11580806 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL11735424 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL11739224 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL11737279 0.92 USP2 (0.56) USP2HTTPLA2G4BLPAR5HSD17B10
SCHEMBL11734597 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL11580000 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL7797300 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3
SCHEMBL11738017 0.92 USP2 (0.61) USP2HTTPLA2G4BLPAR5PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C USP2 883/4885HTT 849/4885PLA2G4B 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.